SpinChip Diagnostics AS announced that it has received NOK 115 million in a equity round of funding from new investor bioMérieux S.A. on March 14, 2024. As a part of the transaction and depending on the outcome of further fund-raising activities undertaken by company, bioMérieux S.A. will hold between 17% to 20% stake in the company, making bioMérieux the second largest shareholder in the company.